World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
50545
World Ranking
5935
National Ranking
3178

Sanjiv J. Shah publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sanjiv J. Shah sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 664 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sanjiv J. Shah D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sanjiv J. Shah sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 108 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sanjiv J. Shah is affiliated with Northwestern University in the United States. Their research primarily focuses on the fields of medicine, with a significant emphasis on cardiology and cardiovascular medicine. Other notable subfields include endocrinology, diabetes and metabolism, molecular biology, pulmonary and respiratory medicine, and radiology, nuclear medicine and imaging.

The scientist's work covers several main topics, including:

  • Cardiovascular Function and Risk Factors
  • Heart Failure Treatment and Management
  • Diabetes Treatment and Management
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Cardiac Imaging and Diagnostics
  • Cardiac pacing and defibrillation studies
  • Parathyroid Disorders and Treatments

Among recent significant papers authored or co-authored are:

  • Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction (2022) published in New England Journal of Medicine
  • Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity (2023) published in New England Journal of Medicine
  • SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials (2022) published in The Lancet
  • The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial (2021) published in Nature Medicine
  • Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes (2024) published in New England Journal of Medicine

Sanjiv J. Shah frequently collaborates with several researchers, including:

  • John J.V. McMurray
  • Scott D. Solomon
  • Muthiah Vaduganathan
  • Pardeep S. Jhund
  • Carolyn S.P. Lam

The scientist's work has been published extensively in a number of venues, with a notable volume of publications in:

  • Circulation
  • Journal of the American College of Cardiology
  • Journal of Cardiac Failure
  • European Journal of Heart Failure
  • JACC Heart Failure

Best Publications

  • Spironolactone for Heart Failure with Preserved Ejection Fraction

    Bertram Pitt;Marc A. Pfeffer;Susan F. Assmann;Robin Boineau

  • Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

    Mathew S. Maurer;Jeffrey H. Schwartz;Balarama Gundapaneni;Perry M. Elliott

  • Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction

    Scott D. Solomon;John J.V. McMurray;Inder S. Anand;Junbo Ge

  • Fully Automated Echocardiogram Interpretation in Clinical Practice

    Jeffrey Zhang;Sravani Gajjala;Pulkit Agrawal;Geoffrey H. Tison

  • Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

    Marc A. Pfeffer;Brian Claggett;Susan F. Assmann;Robin Boineau

  • Phenomapping for novel classification of heart failure with preserved ejection fraction.

    Sanjiv J. Shah;Daniel H. Katz;Senthil Selvaraj;Michael A. Burke

  • Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction A Multiorgan Roadmap

    Sanjiv J. Shah;Dalane W. Kitzman;Barry A. Borlaug;Loek van Heerebeek

  • ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of Imaging

    Sharmila Dorbala;Yukio Ando;Sabahat Bokhari;Angela Dispenzieri

  • Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial

    Richard K Burt;Sanjiv J Shah;Karin Dill;Thomas Grant

  • A USA-based registry for pulmonary arterial hypertension: 1982–2006

    Thenappan Thenappan;S. J. Shah;S. Rich;M. Gomberg-Maitland

  • Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction

    Margaret May Redfield;Kevin J. Anstrom;James A. Levine;Gabe A. Koepp

  • Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction Baseline Findings From the Echocardiographic Study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial

    Amil M. Shah;Sanjiv J. Shah;Inder S. Anand;Nancy K. Sweitzer

  • Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction

    Scott D. Solomon;Brian Claggett;Eldrin F. Lewis;Akshay Desai

  • Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation

    Thenappan Thenappan;S. J. Shah;S. Rich;L. Tian

  • Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.

    Sanjiv J. Shah;Carolyn S.P. Lam;Sara Svedlund;Antti Saraste

  • Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.

    Amil M. Shah;Brian Claggett;Nancy K. Sweitzer;Sanjiv J. Shah

  • The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.

    Michael E Nassif;Sheryl L Windsor;Barry A Borlaug;Dalane W Kitzman

  • Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).

    Mathew S. Maurer;Mazen Hanna;Martha Grogan;Angela Dispenzieri

  • Developing Therapies for Heart Failure With Preserved Ejection Fraction: Current State and Future Directions

    Javed Butler;Gregg C. Fonarow;Michael R. Zile;Carolyn S. Lam

  • Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction : The SOCRATES-REDUCED Randomized Trial.

    Mihai Gheorghiade;Stephen J. Greene;Javed Butler;Gerasimos Filippatos

Frequent Co-Authors

Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Donald M. Lloyd-Jones
Donald M. Lloyd-Jones Northwestern University
Brian Claggett
Brian Claggett Brigham and Women's Hospital
Marc A. Pfeffer
Marc A. Pfeffer Harvard Medical School
Carolyn S.P. Lam
Carolyn S.P. Lam National University of Singapore
Inder S. Anand
Inder S. Anand University of Minnesota
Joao A.C. Lima
Joao A.C. Lima Johns Hopkins University School of Medicine
Akshay S. Desai
Akshay S. Desai Brigham and Women's Hospital
Eldrin F. Lewis
Eldrin F. Lewis Stanford University
Mihai Gheorghiade
Mihai Gheorghiade Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related fields can open new doors for those interested in a healthcare career or supporting roles in medicine. One accessible option is adn nursing programs, which often allow students to quickly enter nursing with a two-year associate degree. These programs are designed for those who want direct patient care experience and may offer more flexible admissions criteria.

For students interested in the administrative side, consider studying at medical billing and coding schools with financial aid. These programs teach skills essential for managing health records and insurance billing, and financial aid options can make them more accessible.

Some prospective nurses aim to find nursing schools that don't require teas or hesi, removing standardized testing from the admissions process. This helps streamline entry into nursing, especially for those concerned about exam barriers.

Additionally, those interested in leadership can complete healthcare administration online degree programs to prepare for management roles in healthcare settings. These accelerated online paths allow students to quickly gain qualifications to oversee medical facilities and services.

Best Scientists Citing Sanjiv J. Shah

Trending Scientists

Recently Published Articles